Ferrocenecarboxylic acid was purchased from Abcr
Even though this group of people typically lack functioning beta cells, early studies suggest GLP-1s may still offer value, including: Improved glucose control and insulin sensitivity
And they stimulate insulin release in a glucose-dependent way, which is why they lower blood sugar in diabetics without generally causing hypoglycaemia
Growth Opportunity Mapping across drug types (Semaglutide, Exenatide, Lixisenatide, Liraglutide, Dulaglutide, Others), routes of administration (Oral, Parenteral), indications (Diabetes, Obesity, Others), and regions
The exact prevalence of GLP-1RA-induced acute pancreatitis remains uncertain but, between 2007 and 2025, the MHRA received 1,296 Yellow Card reports of pancreatitis associated with GLP-1RAs or dual GLP-1/GIPRAs